Fas is ubiquitously expressed on a variety of cells and triggers apoptosis, which have critical roles in the immune system. MicroRNAs (miRNAs) have been recently identified as regulators that modulate target gene expression and are involved in diverse biological processes, such as cell proliferation and apoptosis. This study was undertaken to investigate the contribution of miRNA in the regulation of Fas expression and Fas-mediated apoptosis. Bioinformatics analysis indicated that Fas was a potential target of let-7/miR-98 family. Indeed ectopic expression of let-7/miR-98 reduced, whereas knockdown of endogenous let-7/miR-98 increased the expression of Fas at both mRNA and protein levels. Let-7/miR-98 was verified to target Fas 3 0 untranslated region directly by site-directed gene mutagenesis and reporter gene assay. More importantly, introduction of let-7/miR-98 could decrease the sensitivity to Fas-induced apoptosis. Furthermore, let-7/miR-98 expression was reduced in activation-induced cell death process, accompanied by increased expression of Fas. In conclusion, our study first demonstrated that let-7/miR-98 regulated Fas expression and the sensitivity of Fas-mediated apoptosis.
Introduction
Programmed cell death through apoptosis has a fundamental role in a variety of physiological processes. Apoptosis is critical to the development and homeostasis of the immune system. The life-and-death cycle of cells in the immune system is regulated by a group of cell surface protein receptors, which initiate a multitude of signaling processes, influencing a wide array of cellular functions. Among the death receptors, Fas (APO-1/ CD95) is the best characterized and probably the most important death receptor for peripheral T-cell tolerance and activation-induced cell death (AICD).
1,2 Ligation of Fas with Fas ligand (FasL), which is a member of the tumor necrosis factor cytokine family, causes assembly of an intracellular 'death-inducing signaling complex'. Death-inducing signaling complex formation serves as a central relay station to downstream signaling proteins and, more importantly, provides docking sites for critical effectors in the Fas-mediated apoptosis. 3 Although Fas/FasL interaction is not limited to the immune system, it is where most of their functional studies have originated. It is clear that Fas/FasL have a fundamental role in the regulation of the immune system. 2, 4, 5 It is well documented that AICD in peripheral T-cells is mediated through Fas and FasL interaction, and is believed to function as limitation overexpansion of an immune response by eliminating unwanted lymphocytes and elimination autoreactive T-cells during thymic selection. 6 Similar to many cellular cascades, the Fas/ FasL pathway is policed by numerous mediators. Regulation of Fas-mediated apoptosis may occur at many steps along the recruitment-activation pathway. Despite the general progress made in understanding of the death signal initiated from Fas, relatively little is known regarding regulation of Fas expression.
Dysregulation of Fas contributes to many diseases. Expression of Fas is frequently lost or decreased during tumor progression in human colon carcinomas. 7 Germline mutation of Fas is associated with autoimmune lymphoproliferative syndrome. [8] [9] [10] Lymphocyte Fas expression and serum soluble Fas were significantly increased in systemic lupus erythematosus, rheumatoid arthritis and inflammatory bowel disease patients.
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The expression of Fas may be tightly regulated by a number of factors. Several proteins were identified to regulate Fas expression, such as TDAG51, 12 nuclear factor-kB 13 and cyclon. 14 Hypermethylation of the CpGrich region within the Fas promoter can regulate Fas expression, 15 indicating that epigenetics refers to modification in Fas expression. Cross-talk between RNA splicing and signaling pathways through endogenous ceramide synthesis and subsequent phosphatase activation is a mechanism that post-transcriptionally modifies Fas gene. 16 Interleukin-1-b inhibits Fas expression on synovial cells at post-transcriptional level with unidentified mechanism.
17 MicroRNAs (miRNAs) are endogenous, non-coding similar to 22-nucleotide RNA molecules that regulate gene expression at post-transcriptional level via mRNA degradation and translational repression. 18 Growing evidences demonstrate that miRNAs have important roles in diverse biological processes, including development, cell differentiation, proliferation, apoptosis and immunity. [19] [20] [21] Several miRNAs are implicated to have roles in cell proliferation and apoptosis. miR-135a induces apoptosis by downregulating Janus kinase-2, which leads to decreased mRNA and protein levels of the antiapoptotic gene Bcl-xL. 22 miR-330 promotes apoptosis in prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation. 23 The role of miRNAs in apoptosis is not fully understood, especially in Fas-mediated apoptosis pathway.
In this study, let-7/miR-98 was revealed to directly regulate the expression of Fas and decrease the sensitivity to Fas-induced apoptosis.
Results and discussion
Fas was identified as a potential target of let-7/miR-98 To search for miRNAs that might regulate human Fas expression, we used TargetScan Let-7/miR-98 S Wang et al interaction of miRNA to the target site. A highly structured region (due to intramolecular bonds formed within the bases in the 3 0 UTR) would be inaccessible for miRNA. 24 The different effect of miR-98 and miR-23 might be due to the secondary structure at the target site. We applied RNA fold program to predict the secondary structure of the Fas 3 0 UTR sequences and found miR-98-binding site in stem-loop region and miR-23-binding site in stem region of mRNA, which might result in the different effect of the two miRNAs on Fas expression (Supplementary Figure S1) .
Let-7/miR-98 targets Fas 3
0 UTR in dose-dependent manner Let-7/miR-98 is one of the first identified miRNA families. 18, 25 Let-7/miR-98 which consists of 12 family members (let-7-a1, a2, a3, b, c, d, e, f1, f2, g, i and miR-98) in human beings is highly conserved across animal species in sequence and timing of expression. 26 It has a great role in cell proliferation, differentiation and oncogenesis. 27 Identification of the target genes of miRNA may help to characterize the diverse functions of miRNA. By bioinformatic analysis, we found a potential binding site for let-7/miR-98 within the 3 0 UTR of Fas. To test whether let-7/miR-98 directly targeted the 3 0 UTR of Fas, we constructed psiCHECK-2 vectors (Promega, Madison, WI, USA) containing the Fas 3 0 UTR with putative let-7/miR-98-binding site. In addition, constructs with the 3 0 -GCTCTACCTCA-5 0 to 3 0 -AATATAAT CAT-5 0 mutation at the putative binding sites were generated (Figure 2a) . We then transfected into HeLa cells with the luciferase vector containing a wild-type or mutant let-7/miR-98 response element. We cotransfected these cells with control, let-7/miR-98 mimic or miR-98 inhibitor (anti-miR-98) and measured luciferase activity. miR-98 or let-7 decreased luciferase activity of the reporter vector containing the let-7/miR-98 response element in a dose-dependent manner (Figures 2b and c) . Conversely, anti-miR-98, which could inhibit endogenous miR-98, increased luciferase activity of the reporter vector containing the let-7/miR-98 response element. In contrast, miR-98 had a minimal effect on the reporter vector with a mutated let-7/miR-98 response element 0 UTR luciferase reporter vector and miRNA mimic or inhibitor, along with miRNA mimic or inhibitor controls. At 24 h after transfection, cells were lysed and luciferase activity was measured on a luminometer (TR717; Applied Biosystems, Foster City, CA, USA) by using the Dual-Luciferase Reporter assay system (Promega). The ratio of Renilla luciferase to firefly luciferase was obtained for each well. Let-7/miR-98 S Wang et al (Figure 2d ). Taken together, the above data suggested that let-7/miR-98 directly targeted on the Fas 3 0 UTR. It is now well known that a single miRNA has multiple targets and regulates a variety of cellular activities through its effect on the expression of multiple target genes in specific cells or tissues. The let-7/miR-98 targets that have been identified include RAS, MYC, HMGA2, IMP-1, CDC25A and CDK6. [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] Our solid results support that Fas is a new target of let-7/miR-98, which suggests let-7/ miR-98 is involved in Fas-mediated function.
Manipulation of miR-98 function resulted in reciprocal alterations of expression of Fas and Fas-mediated apoptosis Fas, as a member of the tumor necrosis factor receptor family, is ubiquitously expressed on a variety of cells and triggers apoptosis. 37 To explore the effect of miR-98 on endogenous Fas expression, we treated HeLa cells with miR-98 mimic or anti-miR-98 for 48 h. Then we measured Fas mRNA expression by real-time quantitative PCR and detected Fas protein expression by fluorescenceactivated cell sorter. miR-98 mimic decreased Fas expression at both the protein and mRNA levels, whereas anti-miR-98 increased Fas expression (Figure 3 , Supplementary Figure S2 , S3), suggesting that Fas expression could be regulated by miR-98 at the mRNA and the protein levels. Let-7/miR-98 might involve in Fasmediated apoptosis through regulation of the expression of Fas. To investigate whether miR-98 regulated Fasmediated apoptosis, we transfected HeLa cells with miR-98 mimic or anti-miR-98, treated them with low endotoxin azide-free purified anti-human Fas antibody to induce apoptosis, and measured apoptosis by fluorescence-activated cell sorter analysis of cells with annexin V and propidium iodide staining. As shown in Figure 4 , miR-98 mimic decreased Fas-mediated apoptosis. Conversely, inhibition of endogenous miR-98 increased Fas-mediated apoptosis. MYC, a target of let-7/miR-98, also modulated the sensitivity of the cells to apoptosis. In our study, it was revealed that let-7/miR-98 strongly regulated Fas and Fas-mediated apoptosis. In view of a single miRNA regulating multiple targets, we can not exclude other targets besides Fas involving in let-7/miR-98 regulated apoptosis.
Changes in miRNA expression have been observed to affect the expression or function of the targeted gene. Loss-or gain-of-function of specific miRNAs seems to be a key event in the genesis of human diseases. 38 It was reported that several let-7/miR-98 family members, including let-7e, let-7i, let-7g, miR-98 and let-7d, were significantly overexpressed in cervical carcinomas compared with normal cervical epithelial tissue. 39 On the contrary, a significant decrease of Fas gene expression was observed in the cervical carcinomas tissues compared with those in the normal tissues. 40 There may be functional connection between let-7/miR-98 and Fas gene in cancers. Human primary CD4 þ T lymphocytes were grown in RPMI 1640 supplemented with 10% fetal bovine serum at 371C in 5% CO2. CD4 þ T lymphocytes were stimulated with anti-CD3 (10 mg ml À1 , Calbiochem) and anti-CD28 (2 mg ml À1 , Calbiochem, San Diego, CA, USA) antibodies. The cells were collected at 0, 24, 72 and 120 h after stimulation. The collected cells were subjected to RNA extraction or Fas membrane protein analysis. Total RNA was extracted from cells by Trizol reagent (Invitrogen). Quantification of let-7/miR-98 expression level was detected by the Taqman microRNA assay kit (Applied Biosystems), and the expression level was normalized to that of RNU48, a reference small nuclear RNA. Taqman microRNA assay was performed in duplicate on a 7900HT real-time instrument (Applied Biosystems). For protein analysis, the collected cells were washed and incubated for 30 min at 4 1C with saturating concentrations of APC conjugated mouse anti-human CD95 monoclonal antibody (eBioscience CA). An irrelevant immunoglobulin G1 monoclonal antibody was used as a control. After three washes in cold buffer, cell analysis was performed on the FACScan.
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Let-7/miR-98 expression downregulated on T-cell receptor stimulation The Fas/FasL pathway has key roles in the regulation of apoptosis within the immune system. In vivo, on repeated T-cell receptor triggering, activated T cells undergo apoptosis through a mechanism called AICD, which is mainly mediated via the Fas/FasL system. This mechanism has a crucial role in both central and peripheral deletion events involved in tolerance and homeostasis of the immune system. 3 In vitro, the AICD process can be mimicked by crosslinking the T-cell receptor complex with anti-CD3 and anti-CD28 antibodies. To examine whether let-7/miR-98 involved in T cell activation, we investigated the effect of stimulation of T-cell receptor on let-7/miR-98 expression. CD4 þ T lymphocytes, freshly purified from three healthy donors, were stimulated anti-CD3/CD28 antibodies and let-7/ miR-98 levels were measured by quantitative reverse transcriptase-PCR at different times. As shown in Figure 5a , the level of let-7g was almost 10 times amount compared with other let-7/miR-98 family members in non-stimulated CD4 þ T cells, so we identified the time course of let-7g and Fas expression levels. As expected, the expression of let-7g was decreased in AICD process, accompanying with upregulated Fas protein levels ( Figure 5b ). Our data suggested that let-7/miR-98 family involved in AICD process and might serve as regulator of T cell-mediated immune response.
